Date: 2016-08-11
Type of information: Construction of new premises
Compound: Novartis Biotechnology Center in Huningue, France
Company: Jacobs Engineering Group (USA - CA) Novartis (Switzerland)
Therapeutic area: Technology - Services
Type agreement: construction of new premises services contract
Action mechanism:
Disease:
Details: * On August 11, 2016, Jacobs Engineering Group announced it was awarded a contract to expand the Novartis Pharma S.A.S. Biotechnology Center in Huningue, France . Under the terms of the agreement, Jacobs is providing engineering, procurement and construction management services to increase the site’s production capacity by 70 percent and create a second line of purification that allows for multiple drugs to be manufactured simultaneously.
Already one of the world’s largest production facilities for monoclonal antibodies from mammalian cells, the expansion project adds cell culture bioreactors to the site. Jacobs’ services are being led from its operations in Milan, Italy . The $100 million expansion project is scheduled to be completed in four years.
Financial terms:
Latest news:
